What are the steps to manage hypotension with a blood pressure reading of 99/57 mmHg during dialysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Intradialytic Hypotension (BP 99/57 on Norepinephrine 1 mcg/kg/min)

Immediately reduce the ultrafiltration rate or temporarily stop ultrafiltration, place the patient in Trendelenburg position, and administer a 100-250 mL normal saline bolus while reassessing the target dry weight, as this patient is likely below their true dry weight given they require vasopressor support during dialysis. 1, 2

Immediate Interventions During This Dialysis Session

First-Line Actions

  • Stop or reduce ultrafiltration immediately to prevent further intravascular volume depletion, as ultrafiltration is the primary driver of intradialytic hypotension 1, 3
  • Place the patient in Trendelenburg position to improve venous return and cerebral perfusion 3
  • Administer 100-250 mL normal saline bolus to restore intravascular volume 1, 3
  • Maintain MAP ≥65 mmHg during the dialysis session to ensure adequate tissue perfusion and prevent end-organ ischemia (heart, brain, gut, kidneys) 4, 5

Critical Assessment

  • The fact that this patient requires norepinephrine 1 mcg/kg/min AND still has low blood pressure (99/57) during dialysis strongly suggests the target dry weight is set too low 2, 5
  • Review for signs that estimated dry weight is inappropriately low: improving nutritional status with rising albumin/creatinine, recurrent symptomatic hypotension, or paradoxically increased interdialytic weight gains 2, 1

Modifications for Subsequent Dialysis Sessions

Target Weight Reassessment (Most Critical)

  • Increase the target dry weight by 0.5-1.0 kg as the primary intervention, since this patient cannot tolerate current ultrafiltration goals even with vasopressor support 5, 2
  • Target weight should vary treatment-to-treatment based on clinical status; maintaining slightly above estimated dry weight may be appropriate in acute illness 5
  • A target weight that is too low leads to hypotension and faster loss of residual kidney function 5

Ultrafiltration Rate Modifications

  • Limit ultrafiltration rate to <6 mL/h/kg to reduce mortality risk and prevent end-organ ischemia 1, 5
  • Extend dialysis treatment time to >4 hours to allow slower ultrafiltration rates and better hemodynamic stability 1, 2
  • Consider increasing treatment frequency to >3 times per week to reduce per-session ultrafiltration requirements 2

Dialysate Modifications

  • Reduce dialysate temperature to 35-36°C (instead of standard 37°C) to increase peripheral vasoconstriction and reduce hypotensive episodes 1, 2
  • Consider sodium profiling by increasing dialysate sodium concentration early in the session (around 145 mmol/L), followed by stepwise decrease later in treatment 1
    • Caveat: Sodium profiling may increase interdialytic weight gain and thirst, creating a vicious cycle 1
  • Use bicarbonate-containing dialysate instead of acetate-containing dialysate to minimize hypotension 1

Medication Management

Antihypertensive Medication Review

  • Immediately review and likely discontinue or reduce all antihypertensive medications, as this patient is hypotensive and requiring vasopressor support 2, 1
  • If the patient is taking antihypertensives before dialysis, these are likely contributing significantly to intradialytic hypotension 2
  • Consider dialyzability of current medications (e.g., metoprolol is highly dialyzable and may cause rebound effects) 2

Midodrine for Intradialytic Hypotension

  • Administer midodrine 5-10 mg orally 30 minutes before hemodialysis to increase peripheral vascular resistance and enhance venous return 1, 6, 7
  • Midodrine increases standing systolic blood pressure by approximately 15-30 mmHg at 1 hour after dosing, with effects persisting 2-3 hours 6
  • In a study of 21 patients with severe hemodialysis hypotension, midodrine (mean dose 8 mg) significantly increased minimal systolic pressure from 93.1 to 107.1 mmHg during hemodialysis 7
  • Important: Midodrine is removed by dialysis, so timing 30 minutes pre-dialysis is critical 6

Additional Strategies

Dietary and Fluid Management

  • Counsel patient to avoid eating during or immediately before dialysis, as food intake causes splanchnic vasodilation and worsens hypotension 1, 2
  • Maintain sodium intake at 2-3 g/day with regular dietitian counseling 2
  • Limit interdialytic weight gain to <3 kg between sessions 2

Monitoring Considerations

  • The current norepinephrine requirement of 1 mcg/kg/min during dialysis is highly unusual and suggests either severe volume depletion from inappropriate dry weight OR an unexpected cause of hypotension that needs investigation 8
  • Consider whether this is chronic hypotension (systolic <100 mmHg interdialytically), which affects 5-10% of hemodialysis patients and is characterized by reduced peripheral vascular resistance 9

Common Pitfalls to Avoid

  • Do not continue aggressive ultrafiltration in a hypotensive patient requiring vasopressors - this will cause end-organ ischemia and increase mortality risk 5, 1
  • Do not rely solely on predialysis blood pressure measurements - home blood pressure monitoring provides more accurate assessment 4, 2
  • Recognize that both very low (<110 mmHg systolic) and very high blood pressure are associated with increased mortality in dialysis patients; target predialysis systolic BP of 110-140 mmHg for most patients 2
  • Avoid the assumption that all hypotension requires more aggressive ultrafiltration - paradoxically, excessive ultrafiltration may be causing the hypotension 5, 2

References

Guideline

Management of Intradialytic Postural Hypotension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hypotension in Dialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Blood Pressure Management in Hemodialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Arterial hypotension in dialysis].

Nephrologie, 2001

Research

Chronic hypotension in the dialysis patient.

Journal of nephrology, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.